Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Weiss

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Immunological Methods|July 24, 1986
Counterimmunoelectrophoresis for detection of human serum antibody to HTLV-IIIM J Blaser, D L Cohn, H J Cody, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1987
Serologic, immunologic, and clinical features of parenteral drug users from contrasting populationsD Shine, B Moll, E Emeson, et al.
Cytometry|March 15, 1996
Lymphocyte immunoregulatory cells present in semen from human immunodeficiency virus (HIV)-infected individuals: a report from the HIV Heterosexual Transmission StudyT N Denny, J H Skurnick, A Garcia, et al.
AIDS (London, England)|October 1, 1995
Evidence for an effect of human leukocyte antigens on susceptibility to Kaposi's sarcoma related to charge and peptide-binding properties of class I moleculesM Marmor, R Winchester, A Zeleniuch-Jacquotte, et al.
The Journal of Infectious Diseases|April 1, 1987
Four-year prospective study of homosexual men: correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virusW el-Sadr, M Marmor, S Zolla-Pazner, et al.
The Journal of Infectious Diseases|September 1, 1994
Absence of evidence of retrovirus infection in intravenous drug users with idiopathic CD4+ lymphocytopeniaA Heredia, B Joshi, S H Weiss, et al.
Lancet (London, England)|February 9, 1991
Spontaneous lymphocyte proliferation in HTLV-II infectionS Z Wiktor, S Jacobson, S H Weiss, et al.
The Journal of Infectious Diseases|February 1, 1996
Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelopeA Beretta, S H Weiss, G Rappocciolo, et al.
JAMA|June 13, 1986
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic regionM Robert-Guroff, S H Weiss, J A Giron, et al.
The Journal of Infectious Diseases|October 1, 1986
Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual menC R Rinaldo, L A Kingsley, D W Lyter, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Immunological Methods|July 24, 1986
Counterimmunoelectrophoresis for detection of human serum antibody to HTLV-IIIM J Blaser, D L Cohn, H J Cody, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1987
Serologic, immunologic, and clinical features of parenteral drug users from contrasting populationsD Shine, B Moll, E Emeson, et al.
Cytometry|March 15, 1996
Lymphocyte immunoregulatory cells present in semen from human immunodeficiency virus (HIV)-infected individuals: a report from the HIV Heterosexual Transmission StudyT N Denny, J H Skurnick, A Garcia, et al.
AIDS (London, England)|October 1, 1995
Evidence for an effect of human leukocyte antigens on susceptibility to Kaposi's sarcoma related to charge and peptide-binding properties of class I moleculesM Marmor, R Winchester, A Zeleniuch-Jacquotte, et al.
The Journal of Infectious Diseases|April 1, 1987
Four-year prospective study of homosexual men: correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virusW el-Sadr, M Marmor, S Zolla-Pazner, et al.
The Journal of Infectious Diseases|September 1, 1994
Absence of evidence of retrovirus infection in intravenous drug users with idiopathic CD4+ lymphocytopeniaA Heredia, B Joshi, S H Weiss, et al.
Lancet (London, England)|February 9, 1991
Spontaneous lymphocyte proliferation in HTLV-II infectionS Z Wiktor, S Jacobson, S H Weiss, et al.
The Journal of Infectious Diseases|February 1, 1996
Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelopeA Beretta, S H Weiss, G Rappocciolo, et al.
JAMA|June 13, 1986
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic regionM Robert-Guroff, S H Weiss, J A Giron, et al.
The Journal of Infectious Diseases|October 1, 1986
Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual menC R Rinaldo, L A Kingsley, D W Lyter, et al.
Pageof 7